Stevenage, United Kingdom

Colin Michael Edge


 

Average Co-Inventor Count = 5.8

ph-index = 1

Forward Citations = 3(Granted Patents)


Location History:

  • Shanghai, CN (2018)
  • Stevenage, GB (2017 - 2020)

Company Filing History:


Years Active: 2017-2020

where 'Filed Patents' based on already Granted Patents

3 patents (USPTO):

Title: Colin Michael Edge: Innovator in Parkinson's Disease Treatment

Introduction

Colin Michael Edge is a notable inventor based in Stevenage, GB. He has made significant contributions to the field of medical research, particularly in the development of treatments for neurodegenerative diseases. With a total of 3 patents to his name, Edge's work focuses on innovative compounds that target specific kinase activities.

Latest Patents

Among his latest patents, Edge has developed LRRK2 inhibitors for the treatment of Parkinson's disease. This invention relates to novel compounds that inhibit LRRK2 kinase activity, processes for their preparation, and compositions containing them. These compounds are aimed at treating or preventing diseases characterized by LRRK2 kinase activity, including Parkinson's disease, Alzheimer's disease, and amyotrophic lateral sclerosis (ALS). Another patent involves similar compounds as LRRK2 kinase inhibitors, further emphasizing his commitment to addressing these critical health issues.

Career Highlights

Colin Michael Edge is associated with GlaxoSmithKline Intellectual Property Development Limited, where he continues to advance his research and innovations. His work has been instrumental in the development of therapeutic options for patients suffering from debilitating conditions.

Collaborations

Edge has collaborated with notable colleagues, including Xiao Ding and Luigi Piero Stasi, to enhance the scope and impact of his research. These collaborations have fostered a productive environment for innovation and discovery.

Conclusion

Colin Michael Edge stands out as a dedicated inventor whose work in developing LRRK2 inhibitors is paving the way for new treatments for Parkinson's disease and other related conditions. His contributions to medical research are invaluable and continue to inspire advancements in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…